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Likelihood Ratios in the Diagnosis
of Renal Artery Stenosis by
Magnetic Resonance Angiography
Compared With Renal Angiography

Background: Renal angiography (RA) is considered
to be the gold standard for the diagnosis of renal artery
stenosis (RAS). However, it is invasive and potentially
harmful; hence there is a need for an optimal noninvasive
test. Magnetic resonance angiography (MRA) is currently
accepted as the optimal noninvasive test by many. However, its major drawback is its inability to grade quantitatively the degree of stenosis. In this study, likelihood ratios
(LR) were used to compare the diagnostic accuracy of
MRA with that of RA.
Methods: To test the hypothesis that semiquantitatively
graded MRA would correlate with RA, a retrospective
analysis was performed to determine the LR of MRA to
diagnose RAS compared with RA. It was believed that LR
ⱖ10.0 or ⱕ0.1 might generate conclusive changes from
pretest to post-test probabilities. In this study a total of
94 renal arteries from 48 patients were analyzed for RAS
by MRA and RA. Stenoses were graded by MRA as mild

P

(⬍50%), moderate (50% to 75%), or severe (⬎75%); and
by RA as ⬍75% or ⱖ75% stenosis.
Results: The LR was 0.13 (95% CI ⫽ 0.09 to 0.19) for
mild stenosis, 0.11 (95% CI ⫽ 0.08 to 0.15) for moderate
stenosis, and 2.2 (95% CI ⫽ 1.9 to 3.1) for severe stenosis
by MRA.
Conclusions: Nonsevere stenosis can be sufficiently
diagnosed by MRA and may not warrant RA. However, it
may be insufficiently precise to establish severe RAS
based on LR results. Therefore, for severe RAS by MRA,
the decision to obtain RA can be made with the help of
post-test probability, which is determined using pretest
probability and LR. Am J Hypertens 2003;16:987–992
© 2003 American Journal of Hypertension, Ltd.
Key Words: Renal artery stenosis, renal angiography,
magnetic resonance angiography, likelihood ratio.

rimary disorders of the renal arteries typically
involve the large renal arteries, whereas secondary
disorders more frequently affect smaller arteries
and intrarenal vessels. Renal artery stenosis (RAS), attributable to fibromuscular dysplasia (FMD) or atherosclerosis,
represents an important cause of secondary hypertension and
ischemic nephropathy. The disease of FMD comprises a
collection of disorders that variably affect the intima, media,
or adventitia of the vascular tree. This group accounts for
nearly 10% of the cases of RAS and is classically diagnosed
in female individuals 15 to 50 years of age. Typical sites of
involvement are the distal two thirds of the renal artery and its
branches with beaded aneurysmal dilatations. The treatment
of FMD has included angioplasty with or without stenting, or
surgical correction of the stenotic lesions.1,2

Atherosclerotic RAS accounts for 90% of cases, and
usually involves the ostium and the proximal third of the
renal artery. The incidence of this problem increases with
age, particularly in patients with diabetes, hypertension, or
aorto-occlusive or coronary artery disease.3
Although renovascular hypertension may accelerate or
induce malignant hypertension, it is not readily distinguishable clinically from essential hypertension.3 Persons
with the classical features of hypokalemia, abdominal
bruit, an absence of a strong family history of hypertension, duration of hypertension of ⬍2 years, and the onset
of hypertension after the age of 50 years are more likely to
have renovascular hypertension than other causes of hypertension, but none has sufficiently strong positive predictive value to diagnose atherosclerotic RAS readily.3
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Table 1. Demographic characteristics of 48 patients with suspected renal artery stenosis
Gender
Ethnicity
Diabetes
Hypertension
Currently smoking*
Vascular disease†
Aortic aneurysm

Male (22)
White (24)
Yes (17)
⬍2 y (47)
Yes (29)
Yes (33)
Yes (6)

Female (26)
African American (24)
No (31)
⬎2 y (1)
No (19)
No (15)
No (42)

Measurement of pressure gradient benefit after revascularization is considered to be the gold standard for
diagnosing hemodynamically significant RAS in patients
who undergo angioplasty with or without stenting of renal
artery.4 Renal artery angiography is presently the alternative standard modality for diagnosing this condition before
revascularization; however, it is invasive and has significant complications. Clinically, patients with suspected
RAS can be categorized into three risk groups (ie, low,
moderate and high risk) as described by Mann et al.5
Despite the fact that the final confirmation of the presence
of RAS can be done only by RA, accurate delineation of
those with moderate risk for RAS is necessary to avoid
inappropriate invasive angiography and its complications.
The noninvasive test of choice at present seems to be
MRA. Besides the anatomical evaluation of the renal
artery, MRA can provide information about hemodynamic
significance by evaluating the flow, kidney size, symmetry
of enhancement, and poststenotic dilatation. However,
several other modalities to evaluate RAS have been used
to varying degrees, including measurements of plasma
renin activity, captopril renal scintigraphy, intravenous
pyelography, nuclear imaging with diethylenetriaminepentaacetic acid and duplex ultrasonography. Each of
these has its limitations, unfortunately; but most importantly, their sensitivities and specificities are generally too
low to be universally recommended.6
To circumvent in part the shortcomings of the other
modalities and to avoid the complications of renal angiography, we adopted the use of LR in the diagnosis of RAS
by MRA in comparison with RA by applying a previously
described technique.7,8,9 Subsequently, LR was used to
convert the pretest probability of RAS (based on prediction rule) to a post-test probability of RAS, which can help
to identify those patients who require RA.

Methods
The hospital institutional review board approved the research protocol and methods. All patient data were obtained from the medical record database of our tertiary

hospital (an urban-based, 903-bed, academic tertiary care
facility). This is a pure imaging comparison study that
included any patient ⱖ50 years old with a moderate risk of
having RAS (moderate hypertension [diastolic blood pressure ⬎105 mm Hg] that was associated with abdominal
bruit and was refractory to medical therapy (using three or
more antihypertensive medications including a diuretic
with at least another two classes of antihypertensive medications) and stable kidney function for ⬎6 months. The
patients who had acute renal failure, end-stage renal disease, fibromuscular dysplasia, or recent intervention for
RAS were excluded from the study. Patient characteristics
are presented in Table 1.
A total of 94 renal arteries (N ⫽ 48 patients; two
unilateral nephrectomies) were retrospectively analyzed
for stenosis by both techniques. All patients had undergone MRA and renal angiography between July 1, 1997,
and June 30, 2000, for evaluation of possible renovascular
disease. The mean age of the patients was 59 ⫾ 8 years.
The interval between the two tests was 3 days on average.
The indication for testing was refractory hypertension with
three or more antihypertensive medications (including a
diuretic with at least another two classes of antihypertensive medications) and no overt clinical features of any
other cause of secondary hypertension. None of the patients had any functional evaluation of the renin-angiotensin system. Both tests were performed for all the patients
because the primary team or the primary care physician
who was taking care of the patients was ordering the
MRA, whereas the nephrologists, when consulted, were
ordering the RA.
The MRA studies were conducted with a 1.5 tesla
superconducting unit (General Electric Medical Systems,
Signa 1.5T Horizon Platform, Voorhees, NJ), using a
three-dimensional gradient-echo sequence and a rapid
low-angle shot with a repetition time of 3.8 msec. An
unenhanced study was acquired as a reference scan before
administration of radiocontrast. A 25-mL bolus of intravenous57 Gd was followed by 25 mL of normal saline.
After a 15-second breath-holding interval, a contrast-en-
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Data are numbers of patients. Description of patient demographics. The average blood pressure for the patients was 193/108 mm Hg. The
average serum creatinine and BUN were 1.9 (1.4 to 2.6) mg/dL and 21 (15 to 26) mg/dL, respectively. The average number for blood
pressure medications that were used by the patients was 3.6. The mean pretest probability score was 13, which would correlate on the
prediction rule curve with 48%.
* The average smoking history for the 29 patients was 16 packs-year.
† Vascular diseases include coronary artery disease (28 patients), peripheral vascular disease (9 patients) and carotid artery disease (11
patients). Some patients had more than one vascular disease at the same time.
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hanced MRA was performed during a 30-sec breath-holding period. Angiographic studies were conducted in the
conventional manner by means of femoral percutaneous
cannulation. All the patients had flush aortography. Selective renal angiography is not performed and oblique views
are not obtained routinely because the reconstruction of
the images by the computer provides enough information.
However, when visualization is incomplete, a selective
renal angiogram is obtained with two oblique views (right
anterior oblique [RAO] and left anterior oblique [LAO]).
Pressure gradients are not measured routinely unless revascularization is performed.
Briefly, the technique was as follows. Approximately
30 mL of meglumine diatrizoate was injected into each
renal artery. A radiologist experienced in MRA read the
MR angiographies, and an independent experienced interventional radiologist read all of the renal angiograms.
Stenoses were graded by MRA as mild (⬍50%), moderate
(50% to 75%), or severe (⬎75%). Subjective evaluation of
flow, kidney size, symmetry of enhancement, and poststenotic dilatation was done by the radiologist and that was
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considered in grading the stenosis. Spin dephasing on the
computer was not done. By RA, stenoses were categorized
as ⬍75% or ⱖ75%. These degrees of stenosis were chosen
based on previous studies.6,10 –14 Although severe RAS by
RA or MRA does not necessarily equal clinically significant RAS, they are practically considered to be equal.3,15
The following statistical analyses were generated: 1)
basic group descriptive statistics, including mean, median,
and SD; and 2) likelihood ratios to ascertain the diagnosis
of RAS at different levels of stenosis in MRA and RA.
Statistical analyses were conducted with SPSS, version
10.01 software (SPSS Inc., Chicago, IL).
The LR for mild and moderate stenosis was calculated
by the formula: LR ⫽ 1 ⫺ sensitivity/specificity, as mild
and moderate stenoses were considered to be clinically
insignificant (negative) results. The LR for severe stenosis
was calculated by the formula: LR ⫽ sensitivity/(1 ⫺
specificity), as severe stenosis was considered to be a
significant (positive) result.
The LR modifies the pretest probability of a given
diagnostic test for a suspected disorder. A value of LR ⫽
1.0 indicates that the post-test probability of a suspected
disorder has not changed from its pretest probability. A
value of LR ⬍1.0 indicates a decrease and LR ⬎1.0
indicates an increase in the post-test probability of the
target disorder. Moreover, LR ⱖ10.0 or ⱕ0.1 generate
large and often conclusive changes from pretest to posttest probabilities. Values of LR of 5.0 to 10.0 and of 0.1 to
0.2 generate moderate revisions of the pretest probability,
whereas LR of 2.0 to 5.0 and 0.5 to 0.2 represent smaller
but occasionally important alterations in the pretest probability. Likelihood ratios from 1.0 to 2.0 and from 0.5 to
1.0 are generally clinically unimportant.7,8
Post-test odds were calculated by multiplying the pretest odds ratio (OR) by the calculated LR. Pretest OR were
calculated from pretest probabilities as follows: Pretest
OR ⫽ Pretest Probability/[1 ⫺ Pretest Probability]. The
post-test odds can be converted to probabilities by the
equation: Probability ⫽ Odds/[Odds ⫹ 1]. Post-test probability can also be determined from the LR and the pretest
probability using the nomogram of Fagan as shown in
Fig. 1.9

Results
In an examination of 94 renal arteries from 48 patients
with suspected RAS, MRA revealed mild stenosis in 20
renal arteries, moderate stenosis in 16, and severe stenosis
in 58 (Table 2). The RA disclosed ⬍75% stenosis in 51
arteries and ⱖ75% stenosis in 43 arteries. Data on the
location of the stenosis was not collected. A total of 18
arteries with mild stenosis by MRA had ⬍75% stenosis by
RA. Only two arteries with mild MRA-demonstrable stenosis had ⱖ75% stenosis by RA. These results yielded an
LR of 0.13 (95% CI ⫽ 0.09 to 0.19) when MRA was
considered as mild. Thirteen arteries were categorized
moderately stenotic by MRA and ⬍75% stenotic by RA,
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FIG. 1. Nomogram illustrating how to calculate post-test probabilities from likelihood ratios. The extension of a line that connects the
pretest probability to the likelihood ratio (LR) will yield the post-test
probability. For example, if the clinical scenario of a patient with
renal artery stenosis in question suggests a pretest probability of
50% and the MRA demonstrates moderate stenosis, then the posttest probability will be 10%; in this study the LR for moderate
stenosis by MRA is 0.11. (Adapted from Reference 9, with permission).
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Table 2. Results of renal angiography and magnetic resonance angiography in 94 renal arteries from 48
patients with suspected renal artery stenosis

Mild MRA
Moderate MRA
Severe MRA
Total

RAS <75%

RAS >75%

Total

LR (95% CI)

18
13
20
51

2
3
38
43

20
16
58
94

0.13 (0.09–0.19)
0.11 (0.08–0.15)
2.2 (1.9–3.1)

whereas three arteries that were moderately stenotic by
MRA, had ⱖ75% stenosis by RA. These data yielded a LR
of 0.11 (95% CI ⫽ 0.08 to 0.15) when MRA was described as moderate. However, from a total of 58 arteries,
20 arteries with known severe stenosis by MRA had
⬍75% angiographically proven stenosis, whereas 38 arteries with severe stenosis by MRA had ⱖ75% angiographically proven stenosis. These data yielded a LR of
2.2 (95% CI ⫽ 1.9 to 3.1) when the MRA was graded as
severe.

Discussion
The technique of MRA has rapidly evolved as the noninvasive diagnostic method of choice for RAS; it is not
associated with any of the significant complications of
angiography, which include hemorrhage, infection, atheroembolism, and acute renal failure. However, noninvasive diagnosis of RAS is challenging.6,9,15 Overall, MRA
has an sensitivity of 93% and a specificity of 83% for the
diagnosis of RAS with lesions graded ⱖ50%. Classification of stenosis by MRA is generally semiquantitatively
graded as mild, moderate, or severe. Angiographic lesions
are usually expressed as clinically significant (ⱖ75% occlusion) or insignificant (⬍75% occlusion).11,12,16,17 We
subsequently elected to translate the semiquantitative terminology applied to MRA to the quantitative RA through
the application of LR.
After determining the LR for a given test, it is combined with its pretest probability to calculate a post-test
probability. Importantly, the pretest probability cannot be
directly used to calculate the LR but first requires conversion to an OR. However, post-test probabilities can easily
be determined with the previously described nomogram of
Fagan,9 which conveniently determines post-test probability from the product of pretest probability and the calculated LR.
The pretest probability can be determined based on a
previously described prediction rule for patients with suspected RAS.18 In the prediction rule for RAS, a score is
assigned to the level or presence of each clinical characteristic in Table 3. These scores are added into a sum
score. The results of the prediction rule may not be reproducible from one center to another because of different

patterns of drug therapy leading to different patterns of
response. This is especially important when using diuretics
to treat unilateral RAS, inasmuch as these agents will not
control blood pressure and may subsequently make antirenin therapy less effective by depleting the intravascular
volume and increasing renin level. However, our patients
had similar characteristics to the those of the prediction
rule study patients. In Fig. 2, the predicted probabilities
can be derived from the sum scores in a graphic manner.
For instance, the sum score for a 49-year-old woman who
had smoked in the past, has no signs or symptoms of
atherosclerotic vascular disease, received a diagnosis of
hypertension 1 year previously, and has a body mass index
of 22 kg/m2, no abdominal bruit, a serum creatinine concentration of 101 mol/L (1.11 mg/dL), and a serum
cholesterol level of 5.4 mmol/L (208.82 mg/dL), and does
not take cholesterol-lowering drugs is 13 (5 ⫹ 2 ⫹ 0 ⫹ 1
⫹ 2 ⫹ 0 ⫹ 3 ⫹ 0). Figure 2 shows that the predicted
probability of RAS in this patient is 50%. If her doctor
proceeded with MRA and if bilateral moderate stenosis
was detected, the physician would subsequently conclude
from the nomogram that the post-test probability for RAS
was only 10%. This calculation would be predicated upon
the determination that the LR in for this set of parameters
was 0.11 (Table 2). Therefore, in this particular circumstance, a more extensive and costly evaluation such as
renal arteriography would be much less warranted.
In this retrospective analysis, MRA was performed for
suspected RAS. In cases of mild to moderate RAS diagnosed by MRA, 31 of the 35 (89%) arteries evaluated were
angiographically confirmed to have mild or moderate stenosis. In cases of severe RAS diagnosed by MRA, only 38
of 58 (65%) arteries evaluated, were subsequently established to have ⬎75% stenosis by RA, consequently producing a high false-positive rate by MRA. Although there
is no definite explanation for this observation, several
factors may have produced this high false-positive rate
with a resultant lack of specificity: 1) there is interobserver
variability; 2) studies may be interpreted differently when
there is kinking of the renal arteries and reconstruction
artifact; and 3) MRA lacks the spatial resolution for adequate visualization of accessory renal arteries (for instance, when severe RAS was diagnosed by MRA, 13

Downloaded from https://academic.oup.com/ajh/article/16/12/987/157616 by Henry Ford Hospital user on 22 June 2022

Data are numbers of patients. Description of the results of the two diagnostic modalities and the calculated likelihood ratios (LR) with 95%
CIs. Two independent radiologists determined the level of stenosis in both the MRA and the RA. For calculation of LR, refer to Methods.
LR ⫽ likelihood ratio; MRA ⫽ magnetic resonance angiography; RAS ⫽ renal artery stenosis.
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Table 3. Prediction rule for quantifying the probability of renal artery stenosis
Score*
Predictors

Former or
Current Smokers

0
1
2
3
4
5
2
1
1
2
3

3
4
4
5
5
6
2
1
1
2
3

0
1
2
3
6
9

0
1
2
3
6
9

1

1

* The sum score is obtained by adding all relevant scores. The sum score can be used to obtain the predicted probability of RAS from Fig. 2.
† For intermediate values, the score can be linearly interpolated.
‡ Femoral or carotid bruit, angina pectoris, claudication, myocardial infarction, cerebrovascular accident, or vascular surgery.
Adapted from Krijnen et al.: A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998;129:705–711, with permission.

errors were made in the case of accessory arteries and
seven errors in the case of main arteries).13,17,19
Because this is a retrospective analysis, a functional
evaluation of the renin-angiotensin system or fractional
flow to each kidney could not be accomplished, and this
may have an impact on the calculation of LR in the
diagnosis of RAS. Using any of the different modalities to
evaluate the renovascular function, such as ACE inhibitor
renography or scintigraphy, and the renal resistive index at
Doppler ultrasonography in patients with suspected RAS,

will definitely enhance the capability of clinicians to determine the significance and the severity of RAS. This will
also be very useful in predicting favorable response to
revascularization.3,5,6
In conclusion, in patients with moderate clinical index of
suspicion for RAS, MRA seems to be sufficient to diagnose
mild to moderate RAS (⬍75% stenosis) and may preclude
performance of RA in these circumstances, inasmuch as LR
in this situation will make huge changes in the probability of
having the disease. However, MRA does not definitively
establish severe RAS (ⱖ75% stenosis). In this situation, the
post-test probability can be calculated using LR and pretest
probability from the prediction rule,18 which can facilitate
decision making with regard to whether to proceed with RA
in suspected cases of RAS. Therefore RA may not be necessary for all MRA-diagnosed cases of severe RAS. We
recommend that screening for RAS with MRA should be
combined with LR, and use of pretest probability from the
prediction rule to facilitate the decision making process about
whether to proceed with RA. Larger prospective
and controlled studies are required to confirm these findings.
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Age, y†
20
30
40
50
60
70
Female sex
Signs and symptoms of atherosclerotic vascular disease‡
Onset of hypertension within 2 y
Body mass index ⬍25 kg/m2
Presence of abdominal bruit
Serum creatinine concentration
40 mol/L (0.44 mg/dL)
60 mol/L (0.66 mg/dL)
80 mol/L (0.88 mg/dL)
100 mol/L (1.1 mg/dL)
150 mol/L (1.65 mg/dL)
200 mol/L (2.2 mg/dL)
Serum cholesterol level ⬎6.5 mmol/L (251.36 mg/dL) or
lipid lowering agent

Persons Who
Never Smoked

992

RATIOS IN DIAGNOSIS OF RENAL ARTERY STENOSIS

AJH–December 2003–VOL. 16, NO. 12

References
1.

2.

3.
4.

6.

7.

8.

9.
10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.
22.
23.

24.

25.

26.

27.
28.
29.
30.

Downloaded from https://academic.oup.com/ajh/article/16/12/987/157616 by Henry Ford Hospital user on 22 June 2022

5.

Bonelli F, McKusick MA, Textor SC: Renal artery angioplasty:
technical results and clinical outcome in 320 patients. Mayo Clin
Proc 1995;70:1041–1052.
Ramsay L, Waller P: Blood pressure response to percutaneous
transluminal angioplasty for renovascular hypertension: an overview of published series. Br Med J 1990;300:569 –572.
Safian R, Textor S: Renal artery stenosis. N Engl J Med 2001;344:
431–442.
Van Jaarsveld B, Krijnen P, Pieterman H, Derkx FH, Deinum J,
Postma CT, Dees A, Woittiez AJ, Bartelink AK, Man in ’t Veld AJ,
Schalekamp MA: The effect of balloon angioplasty on hypertension
in atherosclerotic renal artery stenosis. N Engl J Med 2000;342:
1007–1014.
Mann SJ, Pickering TG: Detection of renovascular hypertension.
Ann Med 1992;117:845–853.
Boudewijn G, Vasbinder C, Nelemans PJ, Kessels A, Kroon A, De
Leeuw P, Van Engelshoven J: Diagnostic tests for renal artery
stenosis in patients suspected of having renovascular hypertension:
a meta-analysis. Ann Med 2001;135:401–411.
Jaechke R, Guyatt G, Sackett D: How to use an article about a
diagnostic test. A. Are the results of the study valid? JAMA 1994;
271:389 –391.
Jaechke R, Guyatt G, Sackett D: How to use an article about a
diagnostic test. B. What are the results and will they help me in
caring for my patients. JAMA 1994;271:703–707.
Fagan TJ: Nomogram for Bayes theorem [letter]. N Engl J Med
1975;293:257.
Vigna C, Pacilli MA, Testa M, Langialonga T, Salvatori MP, Lanna
P: Comparison of steerable continuous-wave versus pulsed-wave
Doppler ultrasonography to renal artery angiography in diagnosing
renal artery stenosis. Am J Cardiol 1998;81:365–367.
Gilfeather M, Yoon HC, Siegelman ES, Axel L, Stolpen AH,
Shlansky-Goldberg RD, Baum RA, Soulen MC, Schnall MD: Renal
artery stenosis: evaluation with conventional angiography versus
gadolinium-enhanced MR angiography. Radiology 1999;210:367–
372.
Fellner C, Strotzer M, Geissler A, Kohler SM, Kramer BK, Spies V:
Renal arteries: evaluation with optimized 2D and 3D time-of-flight
MR angiography. Radiology 1995;196:681–687.
Hany T, Debatin J, Leung D, Pfammatter T: Evaluation of aortic and
renal arteries: comparison of breath-hold, contrast-enhanced, threedimensional MR angiography with conventional catheter angiography. Radiology 1997;204:357–362.
Volk M, Strotzer M, Lenhart M, Manke C, Nitz WR, Seitz J,
Feuerbach S, Link J: Time-resolved contrast-enhanced MR angiog-

raphy of renal artery stenosis: Diagnostic accuracy and inter-observer variability. Am J Radiol 2000;174:1583–1588.
Strotzer M, Fellner CM, Geissler A, Gmeinwieser J, Kohler SM,
Kramer BK: Noninvasive assessment of renal artery stenosis. A
comparison of MR angiography, color Doppler sonography and
intraarterial angiography. Acta Radiol 1995;36:243–247.
Schoenberg S, Prince M, Londy F, Knopp M: Arterial-phase threedimensional gadolinium magnetic resonance angiography of renal
arteries. Invest Radiol 1998;33:506 –514.
Korst MB, Joosten FB, Postma CT, Jager GJ, Krabbe JK, Barentsz
JO: Accuracy of normal-dose contrast-enhanced MR angiography in
assessing renal artery stenosis and accessory renal arteries. Am J
Radiol 2000;174:629 –634.
Krijnen P, Van Jaarsveld B, Steyerberg E, Veld A, Schalekamp M,
Habbema J: A clinical prediction rule for renal artery stenosis. Ann
Med 1998;129:705–711.
Dong Q, Schoenberg SO, Carlos RC, Neimatallah M, Cho KJ,
Williams DM, Kazanjian SN, Prince MR: Diagnosis of renal vascular disease with MR angiography. Radiographics 1999;19:1535–
1554.
Harden P, MacLeod MJ, Rodger RSC: Effect of renal artery
stenting on progression of renovascular failure. Lancet 1997;349:
1133–1139.
Derkx F, Schalekamp M: Renal artery stenosis and hypertension.
Lancet 1994;344:237–239.
Hansen K: Prevalence of ischemic nephropathy in the atherosclerotic population. Am J Kidney Dis 1994;24:615–621.
Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM,
Mossey RT: Renal vascular disease causing end-stage renal disease,
incidence, clinical correlations and outcomes: a 20-year clinical
experience. Am J Kidney Dis 1994;24:622–629.
Dejani H, Eisen TD, Finkelstein FO: Revascularization of renal
artery stenosis in patients with renal insufficiency. Am J Kidney Dis
2000;36:752–758.
Conlon PJ, O’Riordan E, Kalra PA: New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular
disease. Am J Kidney Dis 2000;35:573–587.
Plouin PF, Rossignol P, Bobrie G: Atherosclerotic renal artery
stenosis: to treat conservatively, to dilate or to operate. J Am Soc
Nephrol 2001;12:2190 –2196.
Eardley KS, Lipkin GW: Atherosclerotic renal artery stenosis: is it
worth diagnosing? J Hum Hypertens 1999;13:217–220.
Dunnick NR, Sfakianakis GN: Screening for renovascular hypertension. Radiol Clin North Am 1991;29:497–510.
Textor SC, Wilcox CS: Renal artery stenosis: a common, treatable
cause of renal failure? Annu Rev Med 2001;52:421–442.
Caps MT, Perissonotto C, Zierler RE: Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;
98:2866 –2872.

